Advanced CT Imaging, Radiomics, and Artificial Intelligence to Evaluate Immune Checkpoint Inhibitors’ Effects on Metastatic Renal Cell Carcinoma
Advances in the knowledge of renal cell carcinoma (RCC)’s oncogenesis have led to the development of new therapeutic approaches, such as immune checkpoint inhibitors (ICIs), which have improved the clinical outcomes of metastatic RCC (mRCC) patients. Our literature search led to a series of studies...
Main Authors: | Federico Greco, Bruno Beomonte Zobel, Gianfranco Di Gennaro, Carlo Augusto Mallio |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/13/6/3779 |
Similar Items
-
PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors
by: H. S. Gabryś, et al.
Published: (2022-11-01) -
Adverse Effects of Immune-Checkpoint Inhibitors: A Comprehensive Imaging-Oriented Review
by: Carlo Augusto Mallio, et al.
Published: (2023-05-01) -
Radiogenomics and Texture Analysis to Detect von Hippel–Lindau (VHL) Mutation in Clear Cell Renal Cell Carcinoma
by: Federico Greco, et al.
Published: (2024-04-01) -
Imaging of Renal Medullary Carcinoma
by: Federico Greco, et al.
Published: (2017-03-01) -
Advances in CT features and radiomics of checkpoint inhibitor-related pneumonitis: A short review
by: Jie Huang, et al.
Published: (2023-01-01)